Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Ohm Laboratories Inc. | North Brunswick, NJ, United States | Makes it | No problems foundOct 31, 2024 · 22 inspections |
Recalls
- Apr 13, 2022 · Class II · Mckesson Medical-Surgical Inc. Corporate Office
cGMP deviations: Temperature abuse
Lots: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer. - Mar 13, 2020 · Class II · Sun Pharmaceutical Industries, Inc.
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Lots: Lot #: AA39490, Exp 03/2021 - Mar 13, 2020 · Class II · Sun Pharmaceutical Industries, Inc.
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Lots: Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Doxycycline: every company that makes it
- Form
- capsule, oral
- Strength
- 50 mg
- Approval
- ANDA ANDA065053
- On the market since
- Dec 26, 2000
- Package NDCs
63304-614-0163304-614-0563304-614-1363304-614-20- Official label
- DailyMed (National Library of Medicine), updated Apr 24, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?